ADVISORY BOARD MEDICAL

The advisory board of Pharmact is available for scientific support and the establishment of local academies, also to transport our services to organisations and industry.

OBJECTIVES

The advisory board supports the management of Pharmact AG in questions of public relations and fundraising. Pharmact BioScience GmbH benefits from the advisory approaches of the advisory board, for example in positioning and in matters of development co-operation with institutions and the academic sector.

The broadening of the company’s networks creates opportunities for new contacts with companies, institutions and medical faculties.

EXTRACT – MEMBERS

Prof. Dr. med. Abderahman Machraoui
Cardiologist, Clinical Trials; Bochum, Germany / Maroc

Dr. med. Alexander Strelnikow
Clinical Trials; St. Petersburg, Russ. Federation

Dr. med. Miguel Angel Lopez-Aranda
Cardiologist, Clinical Trials; Benidorm, Spain

Robert E. Johnson, Legal Counsil
General Administration Advisor, Durham, NC, USA

Prof. Dr. med. Bronek M. Boszcyk
Visiting Professor Nottingham Trent University

Prof. Dr. med. Robert Pflugmacher
Universitätsklinikum Bonn, Germany